Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2006 5
2007 3
2008 5
2009 10
2010 11
2011 13
2012 14
2013 7
2014 4
2015 3
2016 4
2017 13
2018 10
2019 12
2020 12
2021 25
2022 23
2023 14
2024 23
2025 9
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Results by year

Citations

29 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
Rethinking prognosis in multiple sclerosis: a multiaxial perspective.
Prosperini L, Tortorella C, Barkhof F, Battistini L, Bodini B, Calabrese M, Chard D, Ciccarelli O, De Stefano N, Enzinger C, Filippi M, Kappos L, Kuhle J, Magliozzi R, Rocca MA, Rovira A, Ruggieri S, Sastre-Garriga J, Schoonheim MM, Sormani MP, Stankoff B, Tintoré M, Yousry T, Montalban X, Gasperini C; MAGNIMS network. Prosperini L, et al. Among authors: calabrese m. Nat Rev Neurol. 2026 May 19. doi: 10.1038/s41582-026-01212-z. Online ahead of print. Nat Rev Neurol. 2026. PMID: 42156973 Review.
Multiple sclerosis (MS) is a condition marked by considerable prognostic uncertainty, despite advances in therapeutic strategies and biomarker development. ...
Multiple sclerosis (MS) is a condition marked by considerable prognostic uncertainty, despite advances in therapeutic strategi …
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.
Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo PS, Longobardi E, Colombo E, Mirabella M, Conte A, Tomassini V, Masini C, Perosino V, Tortorella P, Rocca MA; MUPSO Study Group. Filippi M, et al. J Neurol. 2026 May 4;273(5):302. doi: 10.1007/s00415-026-13830-0. J Neurol. 2026. PMID: 42126632 Free PMC article.
BACKGROUND: Real-world evidence on ocrelizumab in early, minimally pretreated relapsing multiple sclerosis (MS) patients remains limited. OBJECTIVE: To describe baseline demographic, clinical, radiological, and treatment characteristics of the MUSPO cohort. ...
BACKGROUND: Real-world evidence on ocrelizumab in early, minimally pretreated relapsing multiple sclerosis (MS) patients remai …
Structure-function multilayer network integration and cognition in multiple sclerosis.
Breedt LC, Pontillo G, Santos FAN, Vriend C, Prados F, Wink AM, Bisecco A, Cagol A, Calabrese M, Castellaro M, Collorone S, Cortese R, De Stefano N, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Høgestøl EA, Llufriu S, Martinez-Heras E, Solana E, Messina S, Moccia M, Nygaard GO, Palace J, Pinter D, Rocca MA, Toosy A, Valsasina P, Ciccarelli O, Strijbis EM, Barkhof F, Schoonheim MM, Douw L; MAGNIMS study group. Breedt LC, et al. Among authors: calabrese m. Netw Neurosci. 2026 Apr 22;10(2):400-417. doi: 10.1162/NETN.a.545. eCollection 2026. Netw Neurosci. 2026. PMID: 42039096 Free PMC article.
People with multiple sclerosis (MS) often present with cognitive deficits that cannot fully be attributed to focal brain alterations. ...Cognitive dysfunction is common in people with multiple sclerosis (MS). Although network approaches have revealed a …
People with multiple sclerosis (MS) often present with cognitive deficits that cannot fully be attributed to focal brain alter …
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes.
Ziccardi S, Marastoni D, Biasi P, Tamanti A, Pizzini FB, Calderone M, Camera V, Bertolazzo M, Daldosso A, Milocco B, Magliozzi R, Calabrese M. Ziccardi S, et al. Among authors: calabrese m. Ther Adv Neurol Disord. 2026 Apr 7;19:17562864261434351. doi: 10.1177/17562864261434351. eCollection 2026. Ther Adv Neurol Disord. 2026. PMID: 41958532 Free PMC article.
BACKGROUND: Despite the availability of several disease-modifying therapies for multiple sclerosis (MS) patients, the optimal strategy remains debated. High-efficacy therapies may better prevent subclinical disease activity and long-term disability; however, escalat …
BACKGROUND: Despite the availability of several disease-modifying therapies for multiple sclerosis (MS) patients, the optimal …
Dynamic emotion recognition and authenticity detection in multiple sclerosis: preliminary cognitive, behavioral, and neuroimaging evidence.
Ziccardi S, Pezzetta R, Schincariol A, Guarnaccia F, Tamanti A, Marastoni D, Calabrese M, Scarpazza C. Ziccardi S, et al. Among authors: calabrese m. Mult Scler Relat Disord. 2026 May;109:107155. doi: 10.1016/j.msard.2026.107155. Epub 2026 Mar 22. Mult Scler Relat Disord. 2026. PMID: 41904839 Free article.
BACKGROUND: Facial emotion recognition (FER) is affected in multiple sclerosis (MS), impacting interpersonal functioning. Standard FER tests utilize static/posed stimuli, lacking in ecological validity. ...
BACKGROUND: Facial emotion recognition (FER) is affected in multiple sclerosis (MS), impacting interpersonal functioning. Stan …
Machine learning-based combination of the central vein sign, cortical lesions and paramagnetic rim lesions: a web-based tool for the diagnosis of multiple sclerosis.
Wynen M, Vanden Bulcke C, Borrelli S, Gordaliza PM, Stölting A, Guisset F, Cordier C, Martire MS, Tamanti A, Macq B, Sati P, Filippi M, Calabrese M, Absinta M, Reich DS, Bach Cuadra M, Maggi P. Wynen M, et al. Among authors: calabrese m. Brain Commun. 2026 Mar 11;8(2):fcag079. doi: 10.1093/braincomms/fcag079. eCollection 2026. Brain Commun. 2026. PMID: 41884595 Free PMC article.
Multiple sclerosis diagnostic criteria lack optimal specificity, leading to potential misdiagnosis. Advanced magnetic resonance imaging (MRI) biomarkers like the central vein sign, cortical lesions and paramagnetic rim lesions are highly specific to multiple …
Multiple sclerosis diagnostic criteria lack optimal specificity, leading to potential misdiagnosis. Advanced magnetic resonanc …
International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges.
Chan A, Alroughani R, Calabrese M, Havrdová EK, Obeidat AZ, Schmierer K, Andersson M, Bek L, Savarin C, Korich J, Bonsignore L, de Seze J. Chan A, et al. Among authors: calabrese m. Neurol Ther. 2026 Jun;15(3):887-906. doi: 10.1007/s40120-026-00901-7. Epub 2026 Mar 19. Neurol Ther. 2026. PMID: 41854800 Free PMC article. Review.
Relapsing multiple sclerosis (RMS) is a chronic inflammatory disease usually diagnosed at a young age. ...
Relapsing multiple sclerosis (RMS) is a chronic inflammatory disease usually diagnosed at a young age. ...
Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis.
Colman J, Pontillo G, Goodkin O, Foster MA, Mahmoudi N, Wattjes MP, Brunetti A, Gonzalez-Escamilla G, Groppa S, Høgestøl EA, Westlye LT, Messina S, Palace J, Cortese R, De Stefano N, Rovira À, Sastre-Garriga J, Ropele S, Enzinger C, Rocca MA, Filippi M, Bellenberg B, Lukas C, Calabrese M, Castellaro M, Uher T, Vaneckova M, Toosy A, Ciccarelli O, Yousry T, Prados F, Barkhof F, Cole JH; MAGNIMS Study Group. Colman J, et al. Among authors: calabrese m. Hum Brain Mapp. 2026 Apr 1;47(5):e70425. doi: 10.1002/hbm.70425. Hum Brain Mapp. 2026. PMID: 41853885 Free PMC article.
The brain-predicted age difference (brain-PAD) is associated with measures of clinical interest in people with multiple sclerosis (pwMS). Most brain age models rely on 3D T1-weighted scans, which are not routinely acquired in MS clinical practice, limiting their pot …
The brain-predicted age difference (brain-PAD) is associated with measures of clinical interest in people with multiple sclerosis …
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis.
Ziccardi S, Fuchs TA, Martinelli L, Maltempo T, Guarnaccia F, Crescenzo F, Guandalini M, Schiavi GM, Bajrami A, Tamanti A, Camera V, Marastoni D, Benedict RHB, Calabrese M. Ziccardi S, et al. Among authors: calabrese m. Mult Scler Relat Disord. 2026 Apr;108:107080. doi: 10.1016/j.msard.2026.107080. Epub 2026 Feb 16. Mult Scler Relat Disord. 2026. PMID: 41734676 Free article.
Patients underwent 1.5T MRI scans at T0 and T2 (regional cortical/subcortical volumes, cortical thickness, lesion burden) and multiple neuropsychological assessments at the end of follow-up. Significant cognitive decline was defined using reliable change indices and attrib …
Patients underwent 1.5T MRI scans at T0 and T2 (regional cortical/subcortical volumes, cortical thickness, lesion burden) and multiple …
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis.
Marastoni D, Eccher C, Signori A, Anni D, Foschi M, Crescenzo F, Mazziotti V, Virla F, Sicchieri M, Turano E, Tamanti A, Camera V, Ziccardi S, Zanetti G, Pizzini FB, Martini S, Fratucello A, Bonetti B, Sormani MP, Calabrese M. Marastoni D, et al. Among authors: calabrese m. J Neuroinflammation. 2026 Feb 12;23(1):92. doi: 10.1186/s12974-026-03725-2. J Neuroinflammation. 2026. PMID: 41680838 Free PMC article.
Cladribine tablets reduced most of the inflammatory markers in the CSF of patients, with a significant reduction, after correction for multiple comparisons, in levels of sTNFR1, Pentraxin3 and CCL22. No patients accumulated new CLs, and no significant changes in PRLs and c …
Cladribine tablets reduced most of the inflammatory markers in the CSF of patients, with a significant reduction, after correction for mu …
204 results